C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2011
12/22/2011	US20110312965 Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
12/22/2011	US20110312963 P38 map kinase inhibitors
12/22/2011	US20110312953 Anthranilic acid derivatives
12/22/2011	US20110312949 Pharmaceutical use of substituted amides
12/22/2011	US20110312945 Crth2 modulators
12/22/2011	US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor
12/22/2011	US20110312939 New chemical compounds
12/22/2011	US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312933 Oxyindole derivatives with motilin receptor agonistic activity
12/22/2011	US20110312931 Glycine transporter-1 inhibitors, methods of making them, and uses thereof
12/22/2011	US20110312093 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders
12/22/2011	US20110311649 Novel imidazole derivatives
12/22/2011	US20110311593 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin
12/22/2011	US20110311483 Crth2 modulators
12/22/2011	US20110311482 Hepatitis C Virus Inhibitors
12/22/2011	US20110311447 Compounds comprising 4-benzoylpiperidine as a Sigma-1-selective ligand
12/22/2011	US20110309348 Organic light-emitting device
12/22/2011	US20110309338 Materical for organic electroluminescent devices and organic electroluminescent devices made by using the same
12/22/2011	US20110309309 Oxocarbon-, Pseudooxocarbon- and Radialene Compounds and Their Use
12/22/2011	DE102010030187A1 New 4-cyano-2-sulfonylphenyl-pyrazolyl-substituted pyridinones and pyrazinones compounds are human neutrophil elastase inhibitors, useful to treat and prevent e.g. pulmonary arterial hypertension and chronic obstructive pulmonary disease
12/22/2011	DE102010023959A1 Neue Verbindungen als Liganden für Übergangsmetallkomplexe und daraus hergestellte Materialien, sowie Verwendung dazu New compounds as ligands for transition metal complexes and derived materials, and use this
12/22/2011	CA2802535A1 Thioacetate compounds, compositions and methods of use
12/22/2011	CA2802483A1 Crystal of amide compound
12/22/2011	CA2802477A1 Agent for treating hcv infection
12/22/2011	CA2801934A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/21/2011	EP2397479A1 Hetero ring derivative
12/21/2011	EP2397478A1 1,3-diaryl substituted ureas as modulators of kinase activity.
12/21/2011	EP2397477A1 Heterocyclic-substituted piperidine compounds and the uses thereof
12/21/2011	EP2397476A2 Indole derivative having PGD2 receptor antagonist activity
12/21/2011	EP2397471A1 Benzimidazole compounds and their use
12/21/2011	EP2397462A2 Compounds, compositions and methods of treatment for heart failure
12/21/2011	EP2396315A1 Fused pyridine and pyrazine derivatives as kinase inhibitors
12/21/2011	EP2396314A1 Process for preparation of bezoyl amino heterocyclyl compounds
12/21/2011	EP2396313A1 Isotopologues of thalidomide
12/21/2011	EP2396312A1 Isotopologues of lenalidomide
12/21/2011	EP2396307A1 Novel amino azaheterocyclic carboxamides
12/21/2011	EP2396304A1 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
12/21/2011	EP2396301A2 Small molecule bradykinin b1 receptor antagonists
12/21/2011	EP2396295A1 Phenoxy acetic acid derivatives
12/21/2011	EP2396004A1 Selective kinase inhibitors
12/21/2011	EP2395992A2 Chemically programmed vaccination
12/21/2011	EP2395835A1 Agonists and antagonists of the sip5 receptor, and methods of uses thereof
12/21/2011	EP2321295B1 4-(pyridin-4-yl)-1h-[1,3,5]triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases
12/21/2011	EP2307382B1 Aminotetrahydroindazoloacetic acids
12/21/2011	EP2217580B1 Substituted tetrazole compounds and uses thereof
12/21/2011	EP2178859B1 Condensed anthranilamide derivatives as insectisides
12/21/2011	EP2167484B1 Condensed anthranilamide insecticides
12/21/2011	EP2091922B1 2-[1-phenyl-5-hydroxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
12/21/2011	EP1966156B1 New compounds iii
12/21/2011	EP1966139B1 Aspartic protease inhibitors
12/21/2011	EP1880995B1 Method for producing indole derivative having piperidine ring
12/21/2011	EP1763350B1 Nicotinamide derivatives and their use as therapeutic agents
12/21/2011	EP1689724B1 Quinazolinone compounds as anticancer agents
12/21/2011	EP1663971B1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
12/21/2011	EP1567503B1 Pyrazole derivatives useful as cox-i inhibitors
12/21/2011	EP1326841B1 Pyridinone derivatives for treatment of atherosclerosis
12/21/2011	CN1968946B 苯并咪唑酮羧酸衍生物 Benzimidazol-carboxylic acid derivatives
12/21/2011	CN1738817B 玻璃体结合蛋白受体的新的拮抗剂衍生物,它们的制备方法,它们作为药物的应用和包含它们的药物组合物 Vitronectin receptor antagonists new derivatives, processes for their preparation, their use as medicaments and pharmaceutical compositions containing them
12/21/2011	CN102292327A 具有连接有吡啶基的三唑环结构的化合物以及有机电致发光器件 A compound having a pyridyl group connected to the triazole ring structures, and organic electroluminescent devices
12/21/2011	CN102292323A 芳基甲基苯并喹唑啉酮m1受体正向变构调节剂 Aryl methylbenzo -quinazolinon m1 receptor positive allosteric modulator
12/21/2011	CN102292322A 用于治疗例如癌症的疾病的取代的嘧啶 Substituted pyrimidines for the treatment of diseases such as cancer
12/21/2011	CN102292321A 作为前列环素(pgi2)受体调节剂用于治疗该受体相关病症的吡唑基取代的碳酸衍生物 Carbonic acid derivatives as prostacyclin (pgi2) receptor modulators for the treatment of the receptor-associated disorder substituted pyrazole
12/21/2011	CN102292320A 作为glyt-1抑制剂的芳酰基氨基-和杂芳酰基氨基-取代的哌啶类 As glyt-1 inhibitors aroylamino - and heteroaryl acylamino - substituted piperidines
12/21/2011	CN102292318A 制备活化酯的方法 The method for preparing an activated ester of
12/21/2011	CN102285971A 吡唑基喹唑啉酮类化合物及其应用 Pyrazolyl quinazolinone compounds and uses thereof
12/21/2011	CN102285970A 一种埃索美拉唑化合物、制备方法及其药物组合物 One kind of esomeprazole compounds, preparation and pharmaceutical compositions
12/21/2011	CN102285969A N-1-substituted piperidin-4-arylamine derivatives and preparation method and use thereof
12/21/2011	CN102285968A 3-[4-(2,6-二氯苯基)-哌啶-1-亚甲基]-2,5-二取代吲哚的制备方法 3- [4- (2,6-dichlorophenyl) - piperidine-1-methylene] -2,5-disubstituted indole Preparation
12/21/2011	CN102285967A 2-芳基甲硫基-6-(四氢喹啉-1-甲基)-4-嘧啶酮衍生物及其制备方法与应用 2-aryl-methylthio-6- (tetrahydroquinoline-1-methyl) -4-pyrimidone derivatives and preparation method and application
12/21/2011	CN102285966A 3-氟-5-氯吡啶基吡唑酰胺类化合物及其应用 3-fluoro-5-chloro-pyridyl pyrazole amide compounds and their Applications
12/21/2011	CN102285965A N-(氰基烷基)苯甲酰胺类化合物及其应用 N- (cyanoalkyl) benzamide compounds and their application
12/21/2011	CN102285964A 氰基苯甲酰胺类化合物及其应用 Cyanobenzoyl amines and its application
12/21/2011	CN102285963A 3-甲氧基吡唑酰胺类化合物及其应用 3-methoxy-pyrazole amide compounds and their application
12/21/2011	CN101775007B 具有hiv拮抗活性的三环烯类化合物及其制备方法与应用 Tricyclic diene compound and its preparation method and application hiv antagonistic activity
12/21/2011	CN101486683B 哒嗪酮和三嗪酮化合物及其作为药物制剂的用途 Pyridazinone and triazinone compounds and their use as pharmaceutical preparations
12/21/2011	CN101218231B 作为代谢型谷氨酸受体的正变构调节剂的杂环化合物 Positive allosteric modulators of heterocyclic compounds as metabotropic glutamate receptors
12/21/2011	CN101142223B 铂络合物和有机电致发光装置 Platinum complexes and organic electroluminescent devices
12/21/2011	CN101035755B 脱保护的方法 Deprotection method
12/21/2011	CN101031567B 新型杂环NF-κB抑制剂 Novel heterocyclic inhibitors of NF-κB
12/20/2011	US8080666 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
12/20/2011	US8080568 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors
12/20/2011	US8080566 Carbazole inhibitors of histamine receptors for the treatment of disease
12/20/2011	US8080565 Substituted 4-amino-benzylpiperidine compounds
12/20/2011	US8080563 Bicyclic heteroaryl inhibitors of PDE4
12/20/2011	US8080557 Quinazolinedione derivatives as PARP inhibitors
12/20/2011	US8080553 Methods and reagents for the treatment of immunoinflammatory disorders
12/20/2011	US8080552 Pyrimidyl derivatives as protein kinase inhibitors
12/20/2011	US8080551 HIV inhibiting pyrimidines derivatives
12/20/2011	CA2602738C Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
12/20/2011	CA2563846C 4-amino-5-cyanopyrimidine derivatives
12/20/2011	CA2468562C Hydrazonopyrazole derivatives and their use as therapeutics
12/20/2011	CA2449201C Acridone derivatives as labels for fluorescence detection of target materials
12/15/2011	WO2011156775A2 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
12/15/2011	WO2011156610A2 Inhibitors of hepatitis c virus
12/15/2011	WO2011156554A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011	WO2011155793A2 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
12/15/2011	WO2011154739A1 Crystalline forms of thalidomide and processes for their preparation
12/15/2011	WO2011154696A1 Anti-inflammatory agents
12/15/2011	WO2011154555A1 Process for the preparation of dihydropyrrole derivatives

1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 1080